Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004354 · ClinicalTrials.gov registry record
Study of Prevalence and Clinical Phenotype in Patients With Glucocorticoid-Remediable Aldosteronism
A clinical trial, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
NCT00004354 is a clinical trial that has completed, run by National Center for Research Resources (NCRR).
The verdict
NCT00004354 has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
Study Summary
OBJECTIVES: I. Determine the prevalence of glucocorticoid-remediable aldosteronism (GRA) in various hypertensive populations and screen at risk members of GRA pedigrees. II. Investigate other factors regulating blood pressure in GRA (environmental, genetically determined factors). III. Investigate renal and hormonal mechanisms regulating potassium homeostasis in GRA. IV. Describe clinical phenotype of GRA patients. V. Prospectively screen GRA-affected patients with MRI angiography for intracranial aneurysm.
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004354
The ClinicalTrials.gov registry entry for NCT00004354 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00004354 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004354 about?
NCT00004354 is a clinical study titled "Study of Prevalence and Clinical Phenotype in Patients With Glucocorticoid-Remediable Aldosteronism". OBJECTIVES: I. Determine the prevalence of glucocorticoid-remediable aldosteronism (GRA) in various hypertensive populations and screen at risk members of GRA pedigrees. II. Investigate other factors regulating blood pressure in GRA (environmental, genetically determined factors). III. Investigate...
What is the current status of trial NCT00004354?
This trial is currently completed. The study started on 1999-06.
Who is sponsoring clinical trial NCT00004354?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.